-
-
Clinical trial sites and research professionals should be cautious and learn from their peers' mistakes to prevent clinical research (CR) litigation, experts say.
-
Clinical research teams and investigators may find that their traditional strategies for handling incidental findings during a trial are inadequate in this age of genetic research.
-
Investigators too often use informed consent documents that lack the simple language and optimal reading level for communicating information to potential volunteers, an expert says.
-
This single-center, retrospective study examined ICU mortality and various risk factors among critically ill patients who developed bacteremia during their VAP episode.
-
Use of specially trained palliative care teams in the ICU has increased in frequency in recent years. Consultation by these teams tends to occur very late in patients' length of stay. Few studies have been performed evaluating outcomes, such as length of stay.
-
Invasive aspergillosis (IA) is increasingly recognized as a source of infection in immunocompromised ICU patients, but accurate diagnosis remains challenging.
-
In the majority of patients who develop the acute respiratory distress syndrome (ARDS), oxygenation can be supported using increased inspired oxygen concentrations (FIO2) or higher levels of positive end-expiratory pressure (PEEP).
-
Prilosec and Nexium Cleared; Anastrozole over Tamoxifen for Breast Cancer; Antibiotics and Steroids Not for Sinusitis; FDA Actions
-
